SCHEMBL976066

SCHEMBL976066

CC(CN1CCN(C2CCCC2)CC1)C(=O)NC1CCCCC1

nearest known ligand 0.60

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.60
POLB P06746 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CHRM5 P08912 2/20 0.51
CHRM1 P11229 2/20 0.51
CHRM2 P08172 1/20 0.51
CHRM4 P08173 1/20 0.51
CHRM3 P20309 1/20 0.51
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MC4R P32245 1/20 0.43
EPHX2 P34913 2/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL979295 0.75 SIGMAR1 (1.00) SIGMAR1POLBHSD17B10CHRM5CHRM1
SCHEMBL976125 0.75 SIGMAR1 (1.00) SIGMAR1POLBHSD17B10CHRM5CHRM1
SCHEMBL19652101 0.74 SIGMAR1 (0.55) SIGMAR1POLBHSD17B10KDM4EMEN1
SCHEMBL13461316 0.73 POLB (0.44) SIGMAR1POLBKDM4EMEN1KMT2A
SCHEMBL975896 0.72 SIGMAR1 (0.73) SIGMAR1POLBHSD17B10CHRM5CHRM1
SCHEMBL11556798 0.72 SIGMAR1 (0.53) SIGMAR1POLBHSD17B10KDM4EEPHX2
SCHEMBL10308298 0.72 EPHX1 (0.59) SIGMAR1KDM4EEPHX2ALDH1A1
SCHEMBL19696814 0.72 EPHX1 (0.59) SIGMAR1KDM4EEPHX2ALDH1A1
SCHEMBL3268411 0.71 PIK3CD (0.46) SIGMAR1POLBHSD17B10CHRM5CHRM1
SCHEMBL21164490 0.71 POLB (0.45) SIGMAR1POLBMC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO claimed
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed